scispace - formally typeset
S

Sarah M. Clark

Researcher at University of Maryland, Baltimore

Publications -  24
Citations -  711

Sarah M. Clark is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: Hippocampal formation & Kynurenine pathway. The author has an hindex of 13, co-authored 24 publications receiving 547 citations. Previous affiliations of Sarah M. Clark include United States Department of Veterans Affairs.

Papers
More filters
Journal ArticleDOI

Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome

TL;DR: Chronic antidepressant treatment with the serotonin selective reuptake inhibitor, fluoxetine, increased neurogenesis in the Ts65Dn to comparable levels seen in the euploid by augmenting both proliferation and survival of BrdU-labeled cells in the subgranular layer and granule cell layer of the hippocampus, respectively.
Journal ArticleDOI

Quantification of Brain Maturation and Growth Patterns in C57BL/6J Mice via Computational Neuroanatomy of Diffusion Tensor Images

TL;DR: In this paper, diffusion tensor magnetic resonance imaging and computational neuroanatomy are used to quantify postnatal developmental patterns of C57BL/6J mouse brain, and a normative baseline is developed, against which transgenic mice may be compared in genotype-phenotype studies.
Journal ArticleDOI

Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals.

TL;DR: Contrary to expectations, the present results indicate that depression, in the absence of medical illness or an overt inflammatory process, is associated with compromised, rather than increased, KP metabolism in the VLPFC.
Journal ArticleDOI

Environmental neurotoxin-induced progressive model of parkinsonism in rats

TL;DR: In this article, epidemiologic evidence supports a causal link between the consumption of flour made from the washed seeds of the plant, Cycas micronesica, by the Chamorro population of Guam and the development of Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex (ALS/PDC).
Journal ArticleDOI

Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications.

TL;DR: A review of the pharmacokinetics and pharmacodynamics of hydroxynorketamines, as well as their behavioral actions, putative mechanisms of action, and potential therapeutic applications can be found in this paper.